NEW YORK, June 6 (Reuters) – A U.S. judge on Monday found a
pattern of misconduct by Merck & Co including lying
under oath and other unethical practices, freeing Gilead
Sciences Inc from paying any…
The post UPDATE 1-Gilead escapes liability in hepatitis C patent fight with Merck appeared first on NASDAQ.